|
1
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Organisation for Economic Cooperation and
Development (OECD)/European Union, Health at a Glance, . Europe
2020: State of Health in the EU Cycle. OECD Publishing; Paris:
2020
|
|
3
|
Gabriel CA and Domchek SM: Breast cancer
in young women. Breast Cancer Res. 12:2122010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Beadle BM, Woodward WA and Buchholz TA:
The impact of age on outcome in early-stage breast cancer. Semin
Radiat Oncol. 21:26–34. 2011. View Article : Google Scholar
|
|
5
|
Liedtke C, Rody A, Gluz O, Baumann K,
Beyer D, Kohls EB, Lausen K, Hanker L, Holtrich U, Becker S and
Karn T: The prognostic impact of age in different molecular
subtypes of breast cancer. Breast Cancer Res Treat. 152:667–673.
2015. View Article : Google Scholar
|
|
6
|
Zhong W, Tan L, Jiang WG, Chen K, You N,
Sanders AJ, Liang G, Liu Z, Ling Y and Gong C: Effect of younger
age on survival outcomes in T1N0M0 breast cancer: A propensity
score matching analysis. J Surg Oncol. 119:1039–1046. 2019.
View Article : Google Scholar
|
|
7
|
Keegan TH, DeRouen MC, Press DJ, Kurian AW
and Clarke CA: Occurrence of breast cancer subtypes in adolescent
and young adult women. Breast Cancer Res. 14:R552012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Partridge AH, Hughes ME, Warner ET,
Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC,
Winer EP, et al: Subtype-dependent relationship between young age
at diagnosis and breast cancer survival. J Clin Oncol.
34:3308–3314. 2016. View Article : Google Scholar
|
|
9
|
Paluch-Shimon S, Pagani O, Partridge AH,
Abulkhair O, Cardoso MJ, Dent RA, Gelmon K, Gentilini O, Harbeck N,
Margulies A, et al: ESO-ESMO 3rd international consensus guidelines
for breast cancer in young women (BCY3). Breast. 35:203–217. 2017.
View Article : Google Scholar
|
|
10
|
Diab SG, Elledge RM and Clark GM: Tumor
characteristics and clinical outcome of elderly women with breast
cancer. J Natl Cancer Inst. 92:550–556. 2000. View Article : Google Scholar
|
|
11
|
Pinto AE, André S and Soares J: Short term
significance of DNA ploidy and cell proliferation in breast
carcinoma: A multivariate analysis of prognostic markers in a
series of 308 patients. J Clin Pathol. 52:604–611. 1999. View Article : Google Scholar
|
|
12
|
Pinto AE, Pereira T, Santos M, Branco M,
Dias A, Silva GL, Ferreira MC and André S: DNA ploidy is an
independent predictor of survival in breast invasive ductal
carcinoma: A long-term multivariate analysis of 393 patients. Ann
Surg Oncol. 20:1530–1537. 2013. View Article : Google Scholar
|
|
13
|
Pinto AE, Pereira T, Silva GL and André S:
Prognostic relevance of DNA flow cytometry in breast cancer
revisited: The 25-year experience of the Portuguese institute of
oncology of Lisbon. Oncol Lett. 13:2027–2033. 2017. View Article : Google Scholar
|
|
14
|
WHO Classification of Tumours Editorial
Board, . Breast Tumours. WHO Classification of Tumour Series. 5th
edition. Vol 2. International Agency for Research on Cancer; Lyon:
2019
|
|
15
|
Elston CW and Ellis IO: Pathological
prognostic factors in breast cancer. I. The value of histological
grade in breast cancer: Experience from a large study with
long-term follow-up. Histopathology. 19:403–410. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Goldhirsch A, Winer EP, Coates AS, Gelber
RD, Piccart-Gebhart M, Thürlimann B and Senn HJ; Panel members, :
Personalizing the treatment of women with early breast cancer:
Highlights of the st gallen international expert consensus on the
primary therapy of early breast cancer 2013. Ann Oncol.
24:2206–2223. 2013. View Article : Google Scholar
|
|
17
|
Wolff AC, Hammond MEH, Allison KH, Harvey
BE, Mangu PB, Bartlett JMS, Bilous M, Ellis IO, Fitzgibbons P,
Hanna W, et al: Human epidermal growth factor receptor 2 testing in
breast cancer: American society of clinical oncology/college of
american pathologists clinical practice guideline focused update. J
Clin Oncol. 36:2105–2122. 2018. View Article : Google Scholar
|
|
18
|
Ahn S, Woo JW, Lee K and Park SY: HER2
status in breast cancer: Changes in guidelines and complicating
factors for interpretation. J Pathol Transl Med. 54:34–44. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deitch AD, Law H and White RD: A stable
propidium iodide staining procedure for flow cytometry. J Histochem
Cytochem. 30:967–972. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dean PN and Jett JH: Mathematical analysis
of DNA distributions derived from flow microfluorometry. J Cell
Biol. 60:523–527. 1974. View Article : Google Scholar
|
|
21
|
Corder GW and Foreman DI: Nonparametric
statistics: A step-by-step approach. 2nd edition. Wiley; Hoboken,
NJ: 2014
|
|
22
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Desmedt C, Haibe-Kains B, Wirapati P,
Buyse M, Larsimont D, Bontempi G, Delorenzi M, Piccart M and
Sotiriou C: Biological processes associated with breast cancer
clinical outcome depend on the molecular subtypes. Clin Cancer Res.
14:5158–5165. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zavagno G, Meggiolaro F, Pluchinotta A,
Bozza F, Favretti F, Marconato R, Geraci G, Nistri R, Fontana P,
Sorrentino P, et al: Influence of age and menopausal status on
pathologic and biologic features of breast cancer. Breast.
9:320–328. 2000. View Article : Google Scholar
|
|
25
|
Karihtala P, Jääskeläinen A, Roininen N
and Jukkola A: Real-world, single-centre prospective data of age at
breast cancer onset: Focus on survival and reproductive history.
BMJ Open. 11:e0417062021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Azim HA Jr, Nguyen B, Brohée S, Zoppoli G
and Sotiriou C: Genomic aberrations in young and elderly breast
cancer patients. BMC Med. 13:2662015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Anders CK, Hsu DS, Broadwater G, Acharya
CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, et
al: Young age at diagnosis correlates with worse prognosis and
defines a subset of breast cancers with shared patterns of gene
expression. J Clin Oncol. 26:3324–3330. 2008. View Article : Google Scholar
|
|
28
|
Zingh R, Hellman S and Heimann R: The
natural history of breast carcinoma in the elderly: Implications
for screening and treatment. Cancer. 100:1807–1813. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Avci O, Tacar SY, Seber ES and Yetisyigit
T: Breast cancer in young and very young women; Is age related to
outcome? J Cancer Res Ther. 17:1322–1327. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Assi HA, Khoury KE, Dbouk H, Khalil LE,
Mouhieddine TH and El Saghir NS: Epidemiology and prognosis of
breast cancer in young women. J Thorac Dis. 5:S2–S8.
2013.PubMed/NCBI
|
|
31
|
Sheridan W, Scott T, Caroline S, Yvonne Z,
Vanessa B, David V, Karen G and Stephen C: Breast cancer in young
women: have the prognostic implications of breast cancer subtypes
changed over time? Breast Cancer Res Treat. 147:617–629. 2014.
View Article : Google Scholar
|
|
32
|
Van Herck Y, Feyaerts A, Alibhai S,
Papamichael D, Decoster L, Lambrechts Y, Pinchuk M, Bechter O,
Herrera-Caceres J, Bibeau F, et al: Is cancer biology different in
older patients? Lancet Healthy Longev. 2:e663–e677. 2021.
View Article : Google Scholar
|
|
33
|
Wang MX, Ren JT, Tang LY and Ren ZF:
Molecular features in young vs elderly breast cancer patients and
the impacts on survival disparities by age at diagnosis. Cancer
Med. 7:3269–3277. 2018. View Article : Google Scholar
|
|
34
|
Collins LC, Marotti JD, Gelber S, Cole K,
Ruddy K, Kereakoglow S, Brachtel EF, Schapira L, Come SE, Winer EP
and Partridge AH: Pathologic features and molecular phenotype by
patient age in a large cohort of young women with breast cancer.
Breast Cancer Res Treat. 131:1061–1066. 2012. View Article : Google Scholar
|
|
35
|
Lodi M, Scheer L, Reix N, Heitz D, Carin
AJ, Thiébaut N, Neuberger K, Tomasetto C and Mathelin C: Breast
cancer in elderly women and altered clinico-pathological
characteristics: A systematic review. Breast Cancer Res Treat.
166:657–668. 2017. View Article : Google Scholar
|
|
36
|
Kim HJ, Kim S, Freedman RA and Partridge
AH: The impact of young age at diagnosis (age <40 years) on
prognosis varies by breast cancer subtype: A U S. SEER database
analysis. Breast. 61:77–83. 2022. View Article : Google Scholar
|
|
37
|
Massafra R, Bove S, La Forgia D, Comes MC,
Didonna V, Gatta G, Giotta F, Latorre A, Nardone A, Palmiotti G, et
al: An invasive disease event-free survival analysis to investigate
Ki67 role with respect to breast cancer patients' age: A
retrospective cohort study. Cancers (Basel). 14:22152022.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pinto AE, André S, Pereira T, Nóbrega S
and Soares J: Prognostic comparative study of S-phase fraction and
Ki67 index in breast carcinoma. J Clin Pathol. 54:543–549. 2001.
View Article : Google Scholar
|
|
39
|
Callaghan KA, Becker TE, Ellsworth DL,
Hooke JA, Ellsworth RE and Shriver CD: Genomic instability and the
development of metastatic lymph node tumors. Ann Surg Oncol.
14:3125–3132. 2007. View Article : Google Scholar
|
|
40
|
Lischka A, Doberstein N, Freitag-Wolf S,
Koçak A, Gemoll T, Heselmeyer-Haddad K, Ried T, Auer G and
Habermann JK: Genome instability profiles predict disease outcome
in a cohort of 4,003 breast cancer patients. Clin Cancer Res.
26:4606–4615. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shackney SE, Smith CA, Miller BW, Burholt
DR, Murtha K, Giles HR, Ketterer DM and Pollice AA: Model for the
genetic evolution of human solid tumors. Cancer Res. 49:3344–3354.
1989.PubMed/NCBI
|
|
42
|
Sennerstam RB and Strömberg JO: Young
breast cancer patients aged <40 years and tumor DNA ploidy
progression. Anal Quant Cytopathol Histopathol. 39:57–68. 2017.
|
|
43
|
Chatsirisupachai K, Lesluyes T, Paraoan L,
Van Loo P and de Magalhães JP: An integrative analysis of the
age-associated multi-omic landscape across cancers. Nat Commun.
12:23452021. View Article : Google Scholar : PubMed/NCBI
|
